USD 93.74
(2.58%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 4.59 Billion USD | -6.28% |
2022 | 4.9 Billion USD | 13.82% |
2021 | 4.3 Billion USD | 0.96% |
2020 | 4.26 Billion USD | 21.9% |
2019 | 3.49 Billion USD | 3830.34% |
2018 | 89 Million USD | 5.95% |
2017 | 84 Million USD | 6.33% |
2016 | 79 Million USD | 5.33% |
2015 | 75 Million USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 4.54 Billion USD | -0.07% |
2024 Q1 | 4.88 Billion USD | -0.89% |
2023 Q2 | 4.57 Billion USD | 0.05% |
2023 Q1 | 4.57 Billion USD | -6.65% |
2023 Q3 | 4.56 Billion USD | -0.27% |
2023 FY | 4.59 Billion USD | -6.28% |
2023 Q4 | 4.59 Billion USD | 0.61% |
2022 FY | 4.9 Billion USD | 13.82% |
2022 Q4 | 4.9 Billion USD | 16.95% |
2022 Q2 | 4.22 Billion USD | -0.8% |
2022 Q1 | 4.26 Billion USD | -1.02% |
2022 Q3 | 4.19 Billion USD | -0.88% |
2021 FY | 4.3 Billion USD | 0.96% |
2021 Q4 | 4.3 Billion USD | 0.19% |
2021 Q1 | 4.3 Billion USD | 1.01% |
2021 Q2 | 4.3 Billion USD | -0.05% |
2021 Q3 | 4.29 Billion USD | -0.19% |
2020 Q2 | 4.2 Billion USD | 22.62% |
2020 FY | 4.26 Billion USD | 21.9% |
2020 Q4 | 4.26 Billion USD | 0.83% |
2020 Q3 | 4.22 Billion USD | 0.55% |
2020 Q1 | 3.43 Billion USD | -1.94% |
2019 Q1 | - USD | -100.0% |
2019 FY | 3.49 Billion USD | 3830.34% |
2019 Q4 | 3.49 Billion USD | 0.87% |
2019 Q3 | 3.46 Billion USD | 75.95% |
2019 Q2 | 1.97 Billion USD | 0.0% |
2018 Q3 | 87 Million USD | 0.0% |
2018 FY | 89 Million USD | 5.95% |
2018 Q1 | - USD | -100.0% |
2018 Q4 | 89 Million USD | 2.3% |
2017 Q4 | 84 Million USD | 0.0% |
2017 FY | 84 Million USD | 6.33% |
2016 FY | 79 Million USD | 5.33% |
2015 FY | 75 Million USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
AptarGroup, Inc. | 726.45 Million USD | -532.172% |
Baxter International Inc. | 11.06 Billion USD | 58.492% |
Becton, Dickinson and Company | 14.73 Billion USD | 68.839% |
Bausch + Lomb Corporation | 4.53 Billion USD | -1.334% |
Haemonetics Corporation | 797.56 Million USD | -475.809% |
Envista Holdings Corp | 1.5 Billion USD | -204.539% |
ResMed Inc. | 697.31 Million USD | -558.592% |
Teleflex Incorporated | 1.83 Billion USD | -149.742% |
Warby Parker Inc. | 150.17 Million USD | -2958.143% |
West Pharmaceutical Services, Inc. | 157.3 Million USD | -2819.545% |